Here, we investigated whether myocardial-specific overexpression of the human NOX2 gene generates a substrate for AF in mice and evaluated the efficacy of atorvastatin (ATV) administration for inhibiting atrial NOX2 activity and reducing AF induction. The gene discussed is CYBB; the disease is atrial fibrillation.